Main > A1. CORP. INDEX. C-Cm No. 1 > Celgene/P

---

This data is not available for free

Celgene/P's subsections
2008. 02.19. Onco.>JP>Lena
2008. 03.07. Corp. Acq.
2010. 04.08. GI.>Crohns Dis.>P
2010. 04.29. Sr. Man. Succession
2010. 05.27. Onco.>MM Thal
2010. 08.26. Sr VP & CFO
2010. 12.07. Onco.>NHL
2011. 02.16. BoD
2011. 02.16. Onco.>AML & MDS Aza
2011. 11.21. Onco.>MDS Lena
2011. 11.22. Onco.>Prostate C.
2011. 12.22. Sr VP Corp Affairs &
2012. 01.23. BoD
2012. 05.07. Gen. Counsel
2012. 10.02. Onco.>Melanoma
2012. 10.12. Onco.>Lung C.
2013. 06.05. Onco.>MCL
2013. 06.26. MorphoSys AG
2013. 07.18. Onco.>CLL
2013. 09.05. Onco.>MM Poma
2014. 03.21. Rheuma.>PA
2014. 04.24. GI.>Crohns Dis.>G
2014. 05.07. $2.5 B Notes Pricing
2014. 05.22. Org. Changes
2014. 07.09. Rheuma.>AS
2014. 08.06. Onco.>Pancreas C.
2014. 11.21. Derma.>Psoriasis
2015. 02.20. Onco.>MM Lena
2015. 03.02. Onco.>NSCLC
2015. 04.12. Mesoblast
2015. 04.27. Acq. Quanticel Pharma.
2015. 06.29. Juno Therapeutics
2015. 07.14. Acq. Receptos
2015. 09.16. Nurix
2015. 10.30. Onco.>AML A
2016. 04.11. Juno Therapeutics
2016. 06.22. 4 NCI Cancer Centers
2016. 07.15. Onco.>MCL
2016. 12.20. Derma. & Rheuma.
2017. 01.26. Acq. Delinea Inc.
2017. 07.05. Onco.>PD-1 .. BeiGene
2017. 08.01. Onco.>AML A E
2017. 11.01. Debt Notes
2018. 01.07. Acq. Impact Biomedicin
2018. 01.22. Acq. Juno Therapeutics
2018. 03.06. Acq. Juno Therapeutics
2019. 01.03. Acq. By BMS
2019. 01.29. WDR5 Leukemia Therapy
2019. 05.28. Onco.>FL or MZL
2019. 07.19. Behçets Dis.Oral Ulcer
2019. 08.16. Onco.>Myelofibrosis
2019. 11.08. Hemato.>Anemia> ..
Patents
Web-Site
Z - OK

Celgene/P's products
This section has no products